Newsbenzinga
Verrica Pharmaceuticals Doses First U.S. Patient In Second Pivotal Clinical Trial COVE-3
· Published
Article summary
Please check the source for details.
An excerpt from the original article.Loading news article.
Please check the source for details.
An excerpt from the original article.
Comments —
Loading comments…